Literature DB >> 13207665

Clinical evaluation of isoniazid.

G MIDDLEBROOK, S H DRESSLER.   

Abstract

Entities:  

Keywords:  NICOTINIC ACID ISOMERS/therapeutic use; TUBERCULOSIS, PULMONARY/therapy

Mesh：

Substances：

Year:  1954        PMID： 13207665     DOI： 10.1164/art.1954.70.6.1102

Source DB:  PubMed          Journal:  Am Rev Tuberc        ISSN： 0096-0381


× No keyword cloud information.
  6 in total

Review 1.  Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective.

Authors:  Stephen H Gillespie
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  Combined drug treatment of tuberculosis. II. Studies of antimicrobially-active isoniazid and streptomycin serum levels in adult tuberculous patients.

Authors:  W MANDEL; A D HEATON; W F RUSSELL; G MIDDLEBROOK
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

3.  The course of pulmonary tuberculosis in patients excreting organisms which have acquired resistance. Response to continued treatment for a second year with isoniazid alone or with isoniazid plus PAS.

Authors:  C V RAMAKRISHNAN; A L BHATIA; S DEVADATTA; W FOX; A S NARAYANA; J B SELKON; S VELU
Journal:  Bull World Health Organ       Date:  1962       Impact factor: 9.408

4.  Resistant and sensitive strains of Mycobacterium tuberculosis found in repeated surveys among a South Indian rural population.

Authors:  R Narain; P Chandrasekhar; R A Satyanarayanachar; P Lal
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

5.  A concurrent comparison of home and sanatorium treatment of pulmonary tuberculosis in South India.

Authors: 
Journal:  Bull World Health Organ       Date:  1959       Impact factor: 9.408

6.  A concurrent comparison of isoniazid plus PAS with three regimens of isoniazid alone in the domiciliary treatment of pulmonary tuberculosis in South India.

Authors: 
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.